Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Children's Flonase Is Latest Play For Nasal Allergy Spray Market Share

This article was originally published in The Tan Sheet

Executive Summary

Children's Flonase, like Children's Nasacort, is the same formulation and is indicated for the same overall age groups as the original product, but its labeling includes additional detail for use by children.


Related Content

Industry Roundup: Children's Rhinocort, MusclePharm Restructuring
First-In-Class Nasacort OTC Also Originates ‘Children’s’ Label
Nasacort, Flonase Competition Heats Up As Sanofi Appeals NAD Review
Flonase Allergy Relief Exclusivity Sliced Up By Label Carve-Out
Adulturated red yeast rice
Martek/Mead Agreement


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts